160
Views
24
CrossRef citations to date
0
Altmetric
Original Article

The utility of rat jejunal permeability for biopharmaceutics classification system

, , &
Pages 1496-1502 | Received 19 Nov 2008, Accepted 12 May 2009, Published online: 20 Nov 2009
 

Abstract

Purpose: The biopharmaceutical classification system has been developed to provide a scientific approach for classifying drug compounds based on their dose/solubility ratio and human intestinal permeability. Therefore in this study a new classification is presented, which is based on a correlation between rat and human intestinal permeability values. Methods: In situ technique in rat jejunum was used to determine the effective intestinal permeability of tested drugs. Then three dimensionless parameters—dose number, absorption number, and dissolution number (Do, An, and Dn)—were calculated for each drug. Results: Four classes of drugs were defined, that is, class I, D0 < 0.5, Peff(rat) > 5.09 × 10−5 cm/s; class II, Do > 1, Peff(rat) > 5.09 × 10 −5 cm/s; class III, D0 < 0.5, Peff(rat) < 4.2 × 10−5 cm/s; and class IV, Do > 1, Peff(rat) < 4.2 × 10−5 cm/s. A region of borderline drugs (0.5 < Do < 1, 4.2 × 10−5 < Peff(rat) < 5.09 × 10−5 cm/s) was also defined. Conclusion: According to obtained results and proposed classification for drugs, it is concluded that drugs could be categorized correctly based on dose number and their intestinal permeability values in rat model using single-pass intestinal perfusion technique. This classification enables us to remark defined characteristics for intestinal absorption of all four classes using suitable cutoff points for both dose number and rat effective intestinal permeability values.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.